Fennec Pharmaceuticals Announcement on Investor Conferences Participation
![Fennec Pharmaceuticals Announcement on Investor Conferences Participation](https://investorshangout.com/images/blog/ihnews-Fennec%20Pharmaceuticals%20Announcement%20on%20Investor%20Conferences%20Participation.jpg)
Fennec Pharmaceuticals Engages with Investors in Upcoming Conferences
Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a dedicated player in the specialty pharmaceutical industry, is set to participate in a series of investor conferences where its management will also hold one-on-one meetings. These upcoming events are key opportunities for the company to share insights and updates directly with investors.
Details of Notable Conferences
Here are the details of the important conferences where Fennec Pharmaceuticals will have a presence:
H.C. Wainwright Global Investment Conference
Date: September 11, 2024
Time: Presentation from 12:00 p.m. to 12:30 p.m. ET
Location: New York City, Lotte NY Palace Hotel, Holmes 1, 4th Floor
Cantor Fitzgerald Global Healthcare Conference
Date: September 19, 2024
Time: Fireside chat from 8:35 a.m. to 9:05 a.m. ET
Location: New York City, InterContinental Barclay Hotel, Track 3, Grand Ballroom 1
These conferences provide a vital platform for the company to engage with current and potential investors, offering insights into its strategic direction and ongoing developments.
About Fennec Pharmaceuticals
Fennec Pharmaceuticals is focused on innovating in the pharmaceutical sector, primarily through its flagship product, PEDMARK. This product aims to mitigate the risks associated with platinum-induced ototoxicity, particularly in pediatric patients. Following its FDA approval in 2022, PEDMARK also garnered European Commission approval in 2023, followed closely by U.K. authorization later in the same year. Its marketing approval, known as PEDMARQSI in Europe, has granted Fennec a robust marketing presence with Orphan Drug Exclusivity in the U.S. and Pediatric Use Marketing Authorization in Europe, providing extensive data protection in these markets.
Contact Information for Inquiries
If you require more details regarding Fennec Pharmaceuticals, please contact:
Investors
Robert Andrade
Chief Financial Officer
Fennec Pharmaceuticals Inc.
+1 919-246-5299
Corporate & Media Inquiries
Lindsay Rocco
Elixir Health Public Relations
+1 862-596-1304
lrocco@elixirhealthpr.com
Frequently Asked Questions
What is Fennec Pharmaceuticals known for?
Fennec Pharmaceuticals specializes in developing treatments to reduce the risk of ototoxicity in pediatric patients.
When is Fennec participating in the H.C. Wainwright conference?
Fennec will present at the H.C. Wainwright Global Investment Conference on September 11, 2024.
How can investors contact Fennec Pharmaceuticals?
Investors can reach out to Robert Andrade, the Chief Financial Officer, at +1 919-246-5299.
What recent approvals has PEDMARK received?
PEDMARK received FDA approval in September 2022 and European approval in June 2023, with U.K. approval in October 2023.
Why is Fennec's participation in these conferences important?
These conferences allow Fennec to directly inform and engage investors, providing valuable updates on its strategic plans and product developments.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- Morning Market Memo: Key Insights on Major Stocks
- Understanding Old Dominion Freight Line's Short Interest Trends
- The Impact of Investing in Burlington Stores Over a Decade
- Unical Aviation Expands Services with ecube Solutions Acquisition
- Kanzhun's Struggles Highlight Market Dynamics and Investor Sentiment
- A-G Specialty Insurance Enhances Capabilities with New Acquisition
- Lindahl Reed Expands Operations with New Washington Office
- Revolutionary AISPEECH M6 Speakerphone Transforms Meetings
- Commemorating the First Continental Congress with New Stamps
- SolarPanelRecycling.com Earns Accreditation from SEIA
Recent Articles
- EUR/USD Stability as Market Awaits Key US Employment Figures
- Navigating the Coming Interest Rate Cuts: Strategies for You
- Morning Market Memo: Key Insights on Major Stocks
- Market Watch: Stocks React to Labor Data and Earnings Reports
- Analyzing Short Interest Trends in Sherwin-Williams Stock
- Understanding Rivian Automotive's Latest Short Interest Trends
- Understanding Old Dominion Freight Line's Short Interest Trends
- The Impact of Investing in Burlington Stores Over a Decade
- Investment Growth of Commercial Metals Over 5 Years
- Unical Aviation Expands Services with ecube Solutions Acquisition
- Kanzhun's Struggles Highlight Market Dynamics and Investor Sentiment
- A-G Specialty Insurance Enhances Capabilities with New Acquisition
- Lindahl Reed Expands Operations with New Washington Office
- FuelCell Energy Reports Solid Q3 Results with Revenue Growth
- Revolutionary AISPEECH M6 Speakerphone Transforms Meetings
- Commemorating the First Continental Congress with New Stamps
- Discover Infantino's Adorable My 1st Tumbler for Kids
- Dierks Bentley Launches ROW 94 Whiskey with Unique Craftsmanship
- Eagle Protect Highlights Glove Safety Amid Food Recall Rise
- Mesirow Wealth Advisors Recognized as Top Next-Gen Financial Experts
- SolarPanelRecycling.com Earns Accreditation from SEIA
- Agora Unveils Innovative Tools to Transform Real Estate Investing
- Eco Material Technologies' 2023 Report: A Green Revolution in Cement
- BizClik Media Unveils New Editions of Sustainability & EV Magazines
- Enhancing Experiences: Scheerer Bearing's New Digital Catalog
- 2025 Ram 1500's Hurricane Engine Named Among Top Best Engines
- Zencoder Shines at TechCrunch Disrupt 2024 Startup Battlefield
- Manifest Partners with Department of Defense on SBOM Solutions
- Challenges Ahead for Michel Barnier as New Prime Minister
- Relief Bed Partners to Enhance Sleep for Orphans in Africa
- Navigating Political Challenges: Macron's Strategy with Barnier
- Legal Action Against Snapchat for Child Safety Concerns
- Seven & i Board Responds to Couche-Tard's Initial Offer
- Athens Stock Market Sees Positive Growth With Key Sectors Rising
- Understanding the Recent Performance of Israeli Stocks
- Market Overview: Norway's Stocks Decline with Key Movers
- Samson Mow's Bitcoin Predictions: An Omega Candle Ahead?
- Gold Market Shakes as Miners Experience Major Decline
- S&P 500 Forecast: Navigating Market Uncertainty Ahead
- FuelCell Energy's Q3 Performance: Insights and Future Prospects
- Empowering Futures: Tallo Joins Forces with SC Future Makers
- TRIMEDX Earns Spot in 2024 Inspiring Workplaces Rankings
- Intesa Sanpaolo Achieves Top Rankings for Leadership and ESG
- Passenger Preferences Unveiled: Convenience in Coastal Travel
- Harnessing AI for Enhanced Supply Chain Analytics in 2024
- Underwater Welding Equipment Market: Growth Insights and Trends
- Returnable Packaging Sector Projected to Nearly Double by 2033
- Automotive Diagnostic Scan Tool Market Forecast for 2034
- The Astaxanthin Market's Bright Future and Growth Factors
- Exploring the Robust Growth of Non-Alcoholic Drinks Market